Total Funding
13
Total FundingSeries A raised
Growth Score in past quarter
pts
Heat Score 13 in past quarter
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
93368
Xoc Pharmaceuticals is a biopharmaceutical company.
- Scott Borland: CEO & PresidentPast Role: MAP Pharmaceuticals, Senior Vice President
- Robert Fishman: Chief Medical Officer
About the Company
Xoc Pharmaceuticals utilizes state-of-the-art receptor characterization technology and cutting-edge medicinal chemistry to identify product candidates and develop novel therapies to meet the goal of providing improved safety and efficacy for patients. It manages the clinical and regulatory risk in its development programs by leveraging the
extensive pharmacological history of compounds similar to its product candidates.